Cross sectional study

9,955views

Cross sectional study

Year 1

Year 1

Skin histology
Introduction to pharmacology
Skin anatomy and physiology
Wound healing
Introduction to biostatistics
Types of data
Vaccinations
Inflammation
Nuclear structure
Pharmacodynamics: Agonist, partial agonist and antagonist
DNA structure
Anemia: Clinical
Anatomy of the heart
Hypertension
Hypertension: Clinical
Myocardial infarction
Clinical trials
Mitosis and meiosis
Calcium channel blockers
Class III antiarrhythmics: Potassium channel blockers
Pharmacokinetics: Drug elimination and clearance
Pharmacokinetics: Drug metabolism
Pharmacokinetics: Drug absorption and distribution
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Opioid agonists, mixed agonist-antagonists and partial agonists
Cardiac muscle histology
Blood histology
Artery and vein histology
Arteriole, venule and capillary histology
Loop diuretics
Thiazide and thiazide-like diuretics
Potassium sparing diuretics
Osmotic diuretics
Carbonic anhydrase inhibitors
Bone histology
Cartilage histology
Skeletal muscle histology
Central nervous system histology
Peripheral nervous system histology
Diabetes mellitus
Phenylketonuria (NORD)
Homocystinuria
Familial hypercholesterolemia
Fats and lipids
Cholesterol metabolism
Carbohydrates and sugars
Proteins
Extracellular matrix
Cytoskeleton and intracellular motility
Cell signaling pathways
Citric acid cycle
Electron transport chain and oxidative phosphorylation
Amino acid metabolism
Nitrogen and urea cycle
Nucleotide metabolism
Introduction to biostatistics
Types of data
Probability
Mean, median, and mode
Range, variance, and standard deviation
Standard error of the mean (Central limit theorem)
Normal distribution and z-scores
Type I and type II errors
Study designs
Ecologic study
Cross sectional study
Case-control study
Cohort study
Randomized control trial
Sensitivity and specificity
Positive and negative predictive value
Test precision and accuracy
Atrophy, aplasia, and hypoplasia
Hyperplasia and hypertrophy
Metaplasia and dysplasia
Bone tumors
Osteomyelitis
Osteoporosis
Osteomalacia and rickets
Septic arthritis
Cauda equina syndrome
The Oral Microbiota and Systemic Health
Bacterial structure and functions
Nasal cavity and larynx histology
Trachea and bronchi histology
Bronchioles and alveoli histology
Inheritance patterns
Mendelian genetics and punnett squares
Hardy-Weinberg equilibrium
DNA mutations
Neuromuscular junction and motor unit
Pharmacodynamics: Drug-receptor interactions
Cholinergic receptors
Adrenergic receptors
Blood products and transfusion: Clinical
Muscle contraction
Sliding filament model of muscle contraction
Nervous system anatomy and physiology
Parasympathetic nervous system
Slow twitch and fast twitch muscle fibers
Enteric nervous system
Sympathetic nervous system
Resting membrane potential
Neuron action potential
Cell membrane
Selective permeability of the cell membrane
Blood groups and transfusions
Blood components
Oxygen binding capacity and oxygen content
Oxygen-hemoglobin dissociation curve
Body fluid compartments
Movement of water between body compartments
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Clot retraction and fibrinolysis
Carbon dioxide transport in blood
Bones of the vertebral column
Bones of the vertebral column
Joints of the vertebral column
Joints of the vertebral column
Joints of the wrist and hand
Bones of the upper limb
Fascia, vessels and nerves of the upper limb
Anatomy of the brachial plexus
Anatomy of the arm
Muscles of the forearm
Vessels and nerves of the forearm
Muscles of the hand
Anatomy of the sternoclavicular and acromioclavicular joints
Anatomy of the glenohumeral joint
Anatomy of the elbow joint
Anatomy of the radioulnar joints
Paired t-test
Two-sample t-test
Hypothesis testing: One-tailed and two-tailed tests
Methods of regression analysis
Spearman's rank correlation coefficient
Mann-Whitney U test
Chi-squared test
Kaplan-Meier survival analysis
Incidence and prevalence
Relative and absolute risk
Odds ratio
Attributable risk (AR)
Direct standardization
Indirect standardization
Disease causality
Selection bias
Information bias
Confounding
Innate immune system
Complement system
T-cell activation
B-cell activation, differentiation, and contraction
Cell-mediated immunity of natural killer and CD8 cells
Antibody classes
Upper respiratory tract infection
Heart failure
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Miscellaneous lipid-lowering medications
Dyslipidemias: Pathology review
Atherosclerosis and arteriosclerosis: Pathology review
Familial hypercholesterolemia
Deep vein thrombosis and pulmonary embolism: Pathology review
Chronic venous insufficiency
Ischemia
ECG cardiac infarction and ischemia
Angina pectoris
Aneurysms
Asthma: Clinical
Chronic bronchitis
Emphysema
Pulmonary hypertension
Idiopathic pulmonary fibrosis
Bronchiectasis
Lung cancer
Chronic obstructive pulmonary disease (COPD): Clinical
Respiratory distress syndrome: Pathology review
Myocardial infarction
Vasculitis
ACE inhibitors, ARBs and direct renin inhibitors
Adrenergic receptors
Adrenergic antagonists: Alpha blockers
Class II antiarrhythmics: Beta blockers
Adrenergic antagonists: Beta blockers
Antiplatelet medications
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Calcium channel blockers
cGMP mediated smooth muscle vasodilators
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Pulmonary corticosteroids and mast cell inhibitors
Arteriole, venule and capillary histology
Microcirculation and Starling forces
Blood pressure, blood flow, and resistance
Resistance to blood flow
Lymphatic system anatomy and physiology
Laminar flow and Reynolds number
Compliance of blood vessels
Pressures in the cardiovascular system
Physiological changes during exercise
Measuring cardiac output (Fick principle)
Stroke volume, ejection fraction, and cardiac output
Frank-Starling relationship
Pressure-volume loops
Changes in pressure-volume loops
Cardiac work
Cardiac preload
Cardiac afterload
Law of Laplace
Baroreceptors
Renin-angiotensin-aldosterone system
Chemoreceptors
Cardiac conduction system
Action potentials in pacemaker cells
Action potentials in myocytes
Cardiac excitation-contraction coupling
Cardiac contractility
ECG basics
Cerebral circulation
Coronary circulation
Respiratory system anatomy and physiology
Reading a chest X-ray
Lung volumes and capacities
Anatomic and physiologic dead space
Alveolar surface tension and surfactant
Ventilation
Regulation of pulmonary blood flow
Zones of pulmonary blood flow
Pulmonary shunts
Ventilation-perfusion ratios and V/Q mismatch
Airflow, pressure, and resistance
Diffusion-limited and perfusion-limited gas exchange
Gas exchange in the lungs, blood and tissues
Oxygen binding capacity and oxygen content
Oxygen-hemoglobin dissociation curve
Carbon dioxide transport in blood
Carpal tunnel syndrome

Transcript

Watch video only

A cross- sectional study is a study design where an exposure and an outcome are measured at the same time.

For example, let’s say you want to figure out if people who are obese – which means having a body mass index or BMI of 30 or higher - have higher serum cholesterol levels compared to people who are not obese – having a body mass index below 30.

To do this, you might look at the medical records of 100 people to see who has high cholesterol levels and who has low cholesterol levels and compare that to how many people in each group are obese or not obese.

You can think about a cross-sectional study like a snapshot of the population at a certain point in time.

Since you can only collect the information you see in that one moment, you don’t know what happens before or after the snapshot was taken.

So, we can only collect information on prevalence – the proportion of exposures or outcomes that already exist at a certain time – and not incidence – the proportion of new exposures or outcomes that occur in a certain time period.

In terms of prevalence, there’s an outcome prevalence and an exposure prevalence.

The outcome prevalence is the proportion of people who have an outcome in the exposed group and the non-exposed group.

In a cross-sectional study this can be organized in a 2 by 2 table, with the exposure – obesity or no obesity – on the side and the outcome – high or low cholesterol levels – on the top, and each box is labeled a, b, c, or d.

Cell a includes individuals who have high cholesterol and who are obese; cell b includes individuals who have low cholesterol and who are obese; cell c includes individuals who have high cholesterol and who are not obese; and cell d includes individuals who have low cholesterol and who are not obese.

We can calculate an outcome prevalence to figure out if high cholesterol – the outcome – is more prevalent for people who are obese or not obese – the exposure.

Let’s say that there are 50 people in cell a, 15 in cell b, 5 in cell c, and 30 in cell d.

To find the outcome prevalence, we first calculate the proportion of people who have high cholesterol in the group that is obese – so “a” divided by “a plus b”, or 50 divided by 65, which rounds to 0.77.

Then we compare it with the proportion of people who have high cholesterol in the group who are not obese – so “c” divided by “c plus d”, or 5 divided by 35, which rounds to 0.14.

And, 0.77 divided by 0.14 equals 5.5, which means that the people who are obese have about 5.5 times the prevalence of high cholesterol compared to people who are not obese.

We can similarly calculate the exposure prevalence, which is a comparison of the proportion of people who have an exposure in the outcome group and the no outcome groups.

For example, we might calculate the exposure prevalence to figure out if obesity – the exposure – is more prevalent for people who have high cholesterol or low cholesterol – the outcome.

To find the exposure prevalence, we first calculate the proportion of people who are obese in the group that has high cholesterol– so “a” divided by “a plus c”, or 50 divided by 55, which is 0.91.

We then compare it to the proportion of people who are obese in the group that has low cholesterol – so “b” divided by “b plus d”, or 15 divided by 45, which is 0.33.

Key Takeaways

A cross-sectional study is a type of observational study that assesses the relationship between exposures and outcomes at a single point in time. It can be used to study factors associated with an outcome. In a cross-sectional study, data are collected from a group of participants who have been followed for a certain length of time. Data are then analyzed to see if there is an association between the different exposures and the outcome measure. Cross-sectional are usually quick and cheap studies that help to sample large groups of people.